| Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison L Lafferty, J Rance, J Grebely, AR Lloyd, GJ Dore, C Treloar, ... Journal of viral hepatitis 25 (12), 1526-1532, 2018 | 51 | 2018 |
| Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis H Camara, Y Zhang, L Lafferty, AJ Vallely, R Guy, A Kelly-Hanku BMC Public Health 21, 1-14, 2021 | 41 | 2021 |
| Unlocking dimensions of social capital in the prison setting L Lafferty, C Treloar, T Butler, J Guthrie, GM Chambers Health & justice 4 (1), 1-12, 2016 | 40 | 2016 |
| Indicators of social capital in prison: a systematic review L Lafferty, GM Chambers, J Guthrie, T Butler Health & Justice 3 (1), 1-11, 2015 | 32 | 2015 |
| Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting L Lafferty, J Rance, C Treloar Drug and alcohol dependence 183, 96-101, 2018 | 24 | 2018 |
| Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison L Lafferty, C Treloar, GM Chambers, T Butler, J Guthrie Social Science & Medicine 167, 29-36, 2016 | 21 | 2016 |
| Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison L Lafferty, C Treloar, J Guthrie, GM Chambers, T Butler Journal of viral hepatitis 24 (2), 111-116, 2017 | 20 | 2017 |
| “That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison L Lafferty, A Cochrane, Y Sheehan, C Treloar, J Grebely, AR Lloyd International Journal of Drug Policy 99, 103456, 2022 | 18 | 2022 |
| Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the … L Lafferty, J Rance, J Grebely, GJ Dore, AR Lloyd, C Treloar, ... International Journal of Drug Policy 77, 102693, 2020 | 18 | 2020 |
| Structural competency in the post-prison period for people who inject drugs: A qualitative case study C Treloar, S Schroeder, L Lafferty, A Marshall, K Drysdale, P Higgs, ... International Journal of Drug Policy 95, 103261, 2021 | 17 | 2021 |
| A ‘one-stop-shop’point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: the PIVOT study Y Sheehan, EB Cunningham, A Cochrane, M Byrne, T Brown, C McGrath, ... Journal of hepatology 79 (3), 635-644, 2023 | 14 | 2023 |
| A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia J Grebely, C Markus, LM Causer, D Silk, S Comben, AR Lloyd, M Martinez, ... The Lancet Gastroenterology & Hepatology 8 (3), 204-207, 2023 | 13 | 2023 |
| " It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success SE Schroeder, K Drysdale, L Lafferty, E Baldry, AD Marshall, P Higgs, ... International Journal of Drug Policy 101, 103571, 2022 | 13 | 2022 |
| A ‘one-stop-shop’intervention integrating point-of-care HCV RNA testing to enhance hepatitis C testing and treatment uptake among new receptions to prison: The PIVOT Study Y Sheehan, EB Cunningham, A Cochrane, M Byrne, T Brown, C McGrath, ... Proceedings of the International Conference on Health and Hepatitis Care in …, 2021 | 13 | 2021 |
| ‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison J Rance, L Lafferty, C Treloar Critical Public Health 30 (2), 130-140, 2020 | 13 | 2020 |
| Violence and hepatitis C transmission in prison—A modified social ecological model HMS Sazzad, L McCredie, C Treloar, AR Lloyd, L Lafferty Plos one 15 (12), e0243106, 2020 | 11 | 2020 |
| A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons L Lafferty, TC Wild, J Rance, C Treloar Harm Reduction Journal 15 (1), 39, 2018 | 11 | 2018 |
| Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs J Grebely, AB Collins, AA Artenie, R Sutherland, JP Meyer, JA Barocas, ... International Journal of Drug Policy 96, 103469, 2021 | 10 | 2021 |
| Vulnerability and antimicrobial resistance A Broom, M Peterie, K Kenny, J Broom, A Kelly-Hanku, L Lafferty, ... Critical Public Health 33 (3), 308-317, 2023 | 9 | 2023 |
| Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers … L Lafferty, K Smith, L Causer, K Andrewartha, D Whiley, SG Badman, ... Implementation Science Communications 2 (1), 1-12, 2021 | 9 | 2021 |
Carla TreloarUniversity of New South WalesVerified email at unsw.edu.au
